Mackenzie Financial’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,144
Closed -$215K 1540
2024
Q1
$215K Buy
+10,144
New +$189K ﹤0.01% 1311
2018
Q4
Sell
-33,834
Closed -$1.19M 1137
2018
Q3
$1.19M Sell
33,834
-7,166
-17% -$231K ﹤0.01% 728
2018
Q2
$1.14M Buy
41,000
+11,497
+39% +$290K ﹤0.01% 667
2018
Q1
$592K Buy
29,503
+5,014
+20% +$95.9K ﹤0.01% 704
2017
Q4
$469K Buy
24,489
+7,297
+42% +$146K ﹤0.01% 697
2017
Q3
$390K Buy
17,192
+2,470
+17% +$49.8K ﹤0.01% 541
2017
Q2
$294K Buy
+14,722
New +$264K ﹤0.01% 559

Other funds holding AORT

Mackenzie Financial's AORT Position: Q2 2024 in Review

Mackenzie Financial sold out of Artivion (AORT) in Q2 2024, closing a stake of 10,144 shares — an estimated $215K sold.

Mackenzie Financial first reported a position in AORT in Q2 2017 and held it in 7 quarters. The position peaked at $1.19M in Q3 2018. 163 funds tracked by Wall St. Rank hold AORT as of Q2 2024.

  • Mackenzie Financial reported no remaining Artivion position as of Q2 2024 after selling out during the quarter.
  • Mackenzie Financial sold 10,144 Artivion shares in Q2 2024, an estimated $215K.
  • Mackenzie Financial first reported a position in Artivion in Q2 2017 and held it in 7 quarters.
  • Mackenzie Financial's Artivion position peaked at $1.19M in Q3 2018.
  • 163 funds tracked by Wall St. Rank held Artivion as of Q2 2024.

Based on Mackenzie Financial's 13F filing for Q2 2024, filed 14 Aug 2024.